Mexican case report of a never‐treated Laron syndrome patient evolving to metabolic syndrome, type 2 diabetes, and stroke

Glucose and lipid profile together with blood pressure should always be considered for low sera‐IGF‐1 patients. Even when adulthood is reached, IGF‐1 therapy in these patients should be pursued as metabolic and protective cellular effects could be triggered. Real incidence of growth hormone insensit...

Descripción completa

Detalles Bibliográficos
Autores principales: Castilla‐Cortazar, Inma, Femat‐Roldán, Giovana, Rodríguez‐Rivera, Joel, Aguirre, Gabriel A., García‐Magariño, Mariano, Martín‐Estal, Irene, Espinosa, Luis, Díaz‐Olachea, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676289/
https://www.ncbi.nlm.nih.gov/pubmed/29152285
http://dx.doi.org/10.1002/ccr3.1193
_version_ 1783277036615237632
author Castilla‐Cortazar, Inma
Femat‐Roldán, Giovana
Rodríguez‐Rivera, Joel
Aguirre, Gabriel A.
García‐Magariño, Mariano
Martín‐Estal, Irene
Espinosa, Luis
Díaz‐Olachea, Carlos
author_facet Castilla‐Cortazar, Inma
Femat‐Roldán, Giovana
Rodríguez‐Rivera, Joel
Aguirre, Gabriel A.
García‐Magariño, Mariano
Martín‐Estal, Irene
Espinosa, Luis
Díaz‐Olachea, Carlos
author_sort Castilla‐Cortazar, Inma
collection PubMed
description Glucose and lipid profile together with blood pressure should always be considered for low sera‐IGF‐1 patients. Even when adulthood is reached, IGF‐1 therapy in these patients should be pursued as metabolic and protective cellular effects could be triggered. Real incidence of growth hormone insensitivity is still to be uncovered.
format Online
Article
Text
id pubmed-5676289
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56762892017-11-17 Mexican case report of a never‐treated Laron syndrome patient evolving to metabolic syndrome, type 2 diabetes, and stroke Castilla‐Cortazar, Inma Femat‐Roldán, Giovana Rodríguez‐Rivera, Joel Aguirre, Gabriel A. García‐Magariño, Mariano Martín‐Estal, Irene Espinosa, Luis Díaz‐Olachea, Carlos Clin Case Rep Case Reports Glucose and lipid profile together with blood pressure should always be considered for low sera‐IGF‐1 patients. Even when adulthood is reached, IGF‐1 therapy in these patients should be pursued as metabolic and protective cellular effects could be triggered. Real incidence of growth hormone insensitivity is still to be uncovered. John Wiley and Sons Inc. 2017-09-27 /pmc/articles/PMC5676289/ /pubmed/29152285 http://dx.doi.org/10.1002/ccr3.1193 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Castilla‐Cortazar, Inma
Femat‐Roldán, Giovana
Rodríguez‐Rivera, Joel
Aguirre, Gabriel A.
García‐Magariño, Mariano
Martín‐Estal, Irene
Espinosa, Luis
Díaz‐Olachea, Carlos
Mexican case report of a never‐treated Laron syndrome patient evolving to metabolic syndrome, type 2 diabetes, and stroke
title Mexican case report of a never‐treated Laron syndrome patient evolving to metabolic syndrome, type 2 diabetes, and stroke
title_full Mexican case report of a never‐treated Laron syndrome patient evolving to metabolic syndrome, type 2 diabetes, and stroke
title_fullStr Mexican case report of a never‐treated Laron syndrome patient evolving to metabolic syndrome, type 2 diabetes, and stroke
title_full_unstemmed Mexican case report of a never‐treated Laron syndrome patient evolving to metabolic syndrome, type 2 diabetes, and stroke
title_short Mexican case report of a never‐treated Laron syndrome patient evolving to metabolic syndrome, type 2 diabetes, and stroke
title_sort mexican case report of a never‐treated laron syndrome patient evolving to metabolic syndrome, type 2 diabetes, and stroke
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676289/
https://www.ncbi.nlm.nih.gov/pubmed/29152285
http://dx.doi.org/10.1002/ccr3.1193
work_keys_str_mv AT castillacortazarinma mexicancasereportofanevertreatedlaronsyndromepatientevolvingtometabolicsyndrometype2diabetesandstroke
AT fematroldangiovana mexicancasereportofanevertreatedlaronsyndromepatientevolvingtometabolicsyndrometype2diabetesandstroke
AT rodriguezriverajoel mexicancasereportofanevertreatedlaronsyndromepatientevolvingtometabolicsyndrometype2diabetesandstroke
AT aguirregabriela mexicancasereportofanevertreatedlaronsyndromepatientevolvingtometabolicsyndrometype2diabetesandstroke
AT garciamagarinomariano mexicancasereportofanevertreatedlaronsyndromepatientevolvingtometabolicsyndrometype2diabetesandstroke
AT martinestalirene mexicancasereportofanevertreatedlaronsyndromepatientevolvingtometabolicsyndrometype2diabetesandstroke
AT espinosaluis mexicancasereportofanevertreatedlaronsyndromepatientevolvingtometabolicsyndrometype2diabetesandstroke
AT diazolacheacarlos mexicancasereportofanevertreatedlaronsyndromepatientevolvingtometabolicsyndrometype2diabetesandstroke

Ejemplares similares